| Ytd | 117.17% | |
| 1y | 122.49% |
| Open | 20.97 | Prev Close | 21.10 | Low | 20.13 | High | 21.30 | Mkt Cap | 279.30M |
| Vol | 144.60K | Avg Vol | 94.04K | EPS | -0.23 | P/E | N/A | Forward P/E | -81.65 |
| Beta | 0.86 | Short Ratio | 2.43 | Inst. Own | 91.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 17.72 | 200-d Avg | 13.67 | 1yr Est | 26.50 |
ANIK News
BTSG, ANIK and OPHC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 26th, 2
Anika (ANIK) could be a solid choice for shorter-term investors looking to capitalize on the recent
ANIK's strong sales momentum and raised 2026 guidance bolster investor confidence, while Cingal and
Five stocks, including EDRY, OPHC, FET, ANIK and NESR, show strong recent price gains and earnings g
Does Anika Therapeutics (ANIK) have what it takes to be a top stock pick for momentum investors? Let
Five stocks, including OPHC, EDRY, ENVA, ANIK and GEO, show strong recent price gains and earnings g
Anika (ANIK) could be a solid choice for shorter-term investors looking to capitalize on the recent
B. Riley Securities analyst Anderson Schock maintains Anika Therapeutics (NASDAQ:ANIK) with a Buy
Anika Therapeutics, Inc. (ANIK) Q2 2026 Earnings Call Transcript
Anika Therapeutics NASDAQ: ANIK reported higher second-quarter revenue, expanded gross margin and it
Gainers Autonomix Medical (NASDAQ:AMIX) shares moved upwards by 62.5% to $4.47 during Wednesday'
Anika Therapeutics (NASDAQ:ANIK) raises FY2026 sales outlook from $114.000 million-$122.500 million
BEDFORD, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global
BEDFORD, Mass., June 05, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global
Anika Therapeutics is refocusing on HA-based OA pain management and regenerative orthopedic products
Anika Therapeutics, Inc. (ANIK) Q1 2026 Earnings Call Transcript
Anika Therapeutics (NASDAQ:ANIK) affirms FY2026 sales outlook from $114.000 million-$122.500 million
Anika Therapeutics (NASDAQ:ANIK) reported quarterly earnings of $0.27 per share which beat the analy
Grew total company revenue 13%, driven by Commercial Channel strength and favorable OEM Channel orde
BEDFORD, Mass., April 15, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global
On April 10, 2026, Anika Therapeutics Inc (ANIK) shares fell 3.1% to a current price of $14.76. This
BEDFORD, Mass., April 03, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global
As of March 4, 2026, two stocks in the health care sector could be flashing a real warning to invest
2 stocks in healthcare sector flashing warning to investors who value momentum. RSI is an indicator
Anika Therapeutics, Inc. (ANIK) Q4 2025 Earnings Call Transcript
Anika Therapeutics (ANIK) came out with quarterly earnings of $0.31 per share, beating the Zacks Con
Fiscal 2026 GuidanceAnika is providing the following 2026 guidance:Total Company Revenue between $11
Anika Therapeutics (NASDAQ:ANIK) reported quarterly earnings of $0.31 per share which beat the analy
Barrington Research analyst Michael Petusky maintains Anika Therapeutics (NASDAQ:ANIK) with a Out
Anika Therapeutics, Inc. (NASDAQ:ANIK), a global leader in the osteoarthritis ("OA") pain ma
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarte
Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly ear
On Tuesday, 164 companies achieved new lows for the year.
On Thursday, 128 companies set new 52-week lows.
On Wednesday, 155 companies set new 52-week lows.
During Tuesday's trading, 188 companies set new 52-week lows.